Auxier Asset Management Viatris Inc Transaction History

Auxier Asset Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$8.48 - $11.13 $2,560 - $3,361	-302 Reduced 2.91%	10,088 $86,000
Q2 2022 Aug 11, 2022	SELL	$9.95 - $12.27 $487 - $601	-49 Reduced 0.47%	10,390 $109,000
Q4 2021 Mar 01, 2022	SELL	$12.09 - $14.68 $967 - $1,174	-80 Reduced 0.76%	10,439 $141,000
Q3 2021 Nov 18, 2021	BUY	$13.25 - $15.13 $251 - $287	19 Added 0.18%	10,519 $143,000
Q2 2021 Aug 18, 2021	SELL	$12.97 - $16.15 $2,762 - $3,439	-213 Reduced 1.99%	10,500 $150,000
Q1 2021 May 17, 2021	BUY	$13.59 - $18.54 $3,533 - $4,820	260 Added 2.49%	10,713 $150,000
Q4 2020 Mar 05, 2021	BUY	$14.3 - $18.74 $149,477 - $195,889	10,453 New	10,453 $196,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

Stay updated on Auxier Asset Management with notifications on news.